Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma
This study is currently recruiting participants.
Verified June 2011 by Uppsala University
Study NCT01455259   Information provided by Uppsala University

First Received on October 11, 2011.   Last Updated on October 17, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Disseminated Malignant Melanoma
Additional conditions recognized in this trial
Melanoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Interventions listed in this trial
AdCD40L
Sponsors listed in this trial
Uppsala University
Uppsala University Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services